Home DocWire Picks

DocWire Picks

hydroxychloroquine, rheumatologist, rheumatologists

Rheumatologists Weigh In On Hydroxychloroquine and COVID-19

COVID-19 Update: British Data Suggests New Variant Could be More Deadly; Biden to Reinstate...

telehealth

Virtual Care Maintains Quality Cancer Care

Coronavirus. COVID-19. 3D Render

Inflammatory Markers at Admission Predict AKI in Patients with COVID-19

telemedicine, covid-19, Hydroxychloroquine, Secukinumab, interview, rheumatologists, rheumatologist, arthroplasty, arthritis, rheumatic, ixekizumab, RA, rheumatoid, FDA, Rheum Round-up: Five RA Drugs Compared, Two THA Approaches, and more

Rheum Round-up: Telemedicine for Rheumatic Patients, Latino Patients and COVID-19, and more

Dustin Diamond, Known As Screech on ‘Saved By The Bell,’ Starts Stage 4 Lung Cancer Treatment—What Does This Mean?

Dustin Diamond, Known As Screech on ‘Saved By The Bell,’ Starts Stage 4 Lung...

Black Women Have Higher Rates of Breast Cancer Recurrence and Death

Cancer Surpassing Heart Disease as Leading Cause of U.S. Deaths

Myeloma Treatment Improvements Are Less Beneficial to High-Risk Patients

video

Recent Clinical Trials for Newly Diagnosed Multiple Myeloma, with Dr. Raj Chakraborty

Cardio Round-up: FOURIER Analysis, Alcohol AFib Risk; and More

Cardio Round-up: FOURIER Analysis, Alcohol AFib Risk; and More

Load more
Subscribe to RSS
Advertisement